Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective, clinical evaluation of the MolecuLightDX+ with OxySight Module in wound care.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MolecuLightDX+ with OxySight Module | Device | MolecuLightDX+ with OxySight Module is an imaging device intended to acquire fluorescence, oxygenation, thermal, and measurement images of wounds. |
| Measure | Description | Time Frame |
|---|---|---|
| Tissue oxygenation informing fluorescence-guided debridement | Evaluate the feasibility of using tissue oxygenation (StO2) to further inform fluorescence-guided debridement. | up to 1 month |
| Tissue oxygenation changes before and after debridement | Observe and quantify changes in tissue oxygenation (StO2) from before to immediately after fluorescence-guided debridement. | up to 1 month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Adults 18 years and older with surface wounds.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| SerenaGroup Monroeville | Monroeville | Pennsylvania | 15146 | United States |
Not provided
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided